TP53 and cancer: A total of 30 cancer patients, all of Arab-Muslim descent, were found to be carriers of the TP53 p.Arg181Cys variant—16 patients were identified using NGS panels, 8 patients using targeted TP53 p.Arg181Cys PCR based on cascade testing and 4 patients using WES.